Always fun to have a guess at the numbers - still expecting $US30+ million in operating cashflow for the quarter.
The P&L might look something like this(all in USD millions)-
Sales Revenue $67(75,000 ozs @ $895)
Cash cost of sales $30(75,000 ozs @ $400)
Deprec & amort $12
General & admin $3
Interest cost $4
NET EARNINGS(before exchange,hedging & tax)$18
Exchange gain $2
Derivative hedging loss $22
NET LOSS(before tax)$2
The biggest guess here is the amount of ozs produced as the rest of the numbers should fall into line.
- Forums
- ASX - By Stock
- OGC
- running the numbers
running the numbers, page-15
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OGC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online